Open AccessEffect of Atorvastatin on the Disease Activity and Severity of Rheumatoid Arthritis: Double-Blind Randomized Controlled Trial
Author(s) -
Karim Mowla,
Elham Rajai,
Ali Ghorbani,
Mehrdad Dargahi-Malamir,
Mohammad Bahadoram,
Shooka Mohammadi
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/16538.7814
Subject(s) - atorvastatin , medicine , rheumatoid arthritis , erythrocyte sedimentation rate , placebo , randomized controlled trial , arthritis , gastroenterology , physical therapy , pathology , alternative medicine
HMG-CoA (3-hydroxy-3- methylglutary lcoenzyme A) reductase inhibitors (statins) have anti-inflammatory properties which may be particularly useful in rheumatoid arthritis to suppress disease activity and inflammatory factors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom